Skip to main content
OpenTrials
Completed

NCT Number: NCT01692873

Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors

Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat.

Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month.

The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response.

This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Tumor Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreatic Diseases Pancreatic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Marine GILABERT, MD

Marseille, 13009, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspicion of pancreatic adenocarcinoma
  • Patient > 18 years old
  • Social Security affiliation
  • Signed informed consent

Exclusion criteria

  • Patient in emergency situation
  • Major person being the object of a legal protective measure or unable to express its consent

Treatment and study plan

suspected pancreatic tumor

Procedure

Realization of pancreatic surgery to obtain tumor biopsy and blood samples to realize biomarkers analyses.

Primary outcomes

  1. Biomarkers

    Time frame: within twenty four hours

    Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers

Secondary outcomes

  1. Histology

    Time frame: within twenty four hours

    To determine the histologic characteristics of the pancreatic tumor

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Official study title

Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004

Acronym: PACAomics

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Sep 25, 2012
Registry last updated
Apr 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.